Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts FY25 Results Announcement August 29, 2025 2025 Half Year Results August 29, 2025 How to Invest in Gene Stocks and ETFs August 29, 2025